Avidity Biosciences, Inc. (RNA)

72.60 -0.04 (-0.06%) USD  |  NASDAQ  |  Jan 22, 14:50
More

Avidity Biosciences Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for RNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Novartis AG Upgrade
Dyne Therapeutics, Inc. Upgrade
EXACT Sciences Corp. Upgrade
Astria Therapeutics, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade